ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
프레이저 증후군 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 7.4%의 CAGR로 21억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료에 대한 수요 증가, 신생아 검진 프로그램을 통한 조기 진단 증가, 성인지적 의료에 대한 관심 증가, 희귀질환 지원 서비스에 대한 접근성 향상, 선천성 신증후군 유병률 증가 등의 요인에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 유전자 검사 기술의 발전, 호르몬 대체요법의 혁신, 정밀 신장학 도구의 개발, 희귀질환 연구개발에 대한 투자 증가, 소아 비뇨기과 솔루션 기술의 발전 등을 꼽을 수 있습니다.
신장 관련 질환의 유병률 증가는 향후 몇 년 동안 프레이저 증후군 시장의 성장을 촉진할 것으로 예상됩니다. 신장 관련 질환은 신장의 구조와 기능에 영향을 미치는 질환을 포함하며, 노폐물 여과, 체액 균형, 중요한 생리적 과정의 조절과 같은 기능을 제한합니다. 신장 질환의 이환율 증가는 신장 혈관을 손상시키고 그 기능을 손상시키는 당뇨병과 고혈당의 비율 증가가 주요 원인입니다. 프레이저 증후군의 경우 신장 기능에 영향을 미치는 유전자 변이에 초점을 맞추면 신장 관련 질환에 대해 더 깊이 이해할 수 있습니다. 유전적 요인이 신장 질환에 어떻게 관여하는지에 대한 이러한 인사이트는 신장 질환의 진단과 관리에 도움이 될 수 있습니다. 예를 들어, 2024년 12월 호주 보건 복지 연구소는 2022년 만성 신장 질환(CKD)으로 인한 사망자 수는 약 2만 2,000명이며, 사망률은 2021년 10만 명당 56.7명에서 2022년 60.3명으로 증가할 것이라고 보고했습니다. 신장 관련 질환의 증가가 지속되는 가운데, 프레이저 증후군 시장의 확대가 예상됩니다.
희귀질환에 대한 투자 확대는 프레이저 증후군 시장의 성장을 가속화할 것으로 보입니다. 희귀질환은 2,000명당 1명 이하의 비율로 발생하며, 대부분 만성적이고 진행성이며, 생명을 위협하거나 장애를 유발하는 경우가 많습니다. 희귀질환에 대한 투자가 증가하는 배경에는 미충족 의료수요가 인정되고, 희귀질환 치료제 지정, 시장 독점권, 시장개척 비용 절감 등의 규제적 인센티브로 인해 높은 수익을 얻을 수 있는 기회가 있기 때문입니다. 프레이저 증후군은 표적화된 연구개발의 필요성을 강조하고, 틈새에 특화된 효과적인 치료법의 가능성을 보여줌으로써 희귀질환에 대한 투자를 촉진할 수 있습니다. 예를 들어, 미국 비영리단체 Global Genes는 2024년 4월 희귀질환 치료제를 개발하는 기업들이 2024년 1분기에 71억 달러를 조달했다고 보고했습니다. 이러한 희귀질환에 대한 투자 확대는 프레이저 증후군 시장을 더욱 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 프레이저 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 프레이저 증후군 시장 : 성장률 분석
세계의 프레이저 증후군 시장 실적 : 규모와 성장, 2019-2024년
세계의 프레이저 증후군 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계 프레이저 증후군 전체 시장(TAM)
제6장 시장 세분화
세계의 프레이저 증후군 시장 : 치료 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
외과적 개입
호르몬요법
지지요법
유전 상담
세계의 프레이저 증후군 시장 : 진단 방법별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
유전자 검사
임상 평가
영상 기술
생화학 검사
세계의 프레이저 증후군 시장 : 증상별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
요도하열
신증
난청
치아 이상
세계의 프레이저 증후군 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원
진단 센터
조사기관
기타 최종사용자
세계의 프레이저 증후군 시장 : 외과적 개입 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
신적출술
신장 이식
정소 생검
세계의 프레이저 증후군 시장 : 호르몬요법 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
테스토스테론 보충 요법
에스트로겐 요법
성장호르몬 요법
세계의 프레이저 증후군 시장 : 지지요법 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
혈압 관리
신대체요법(투석)
통증 관리
세계의 프레이저 증후군 시장 : 유전 상담 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
임신 전 상담
진단 후 상담
가족 계획 가이던스
제7장 지역별·국가별 분석
세계의 프레이저 증후군 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 프레이저 증후군 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
프레이저 증후군 시장 : 경쟁 구도
프레이저 증후군 시장 : 기업 개요
Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Novo Nordisk Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Genentech Inc
Illumina Inc.
Revvity Inc.
Exact Sciences Corporation
Natera Inc.
PTC Therapeutics
Myriad Genetics Inc.
Fulgent Genetics Inc.
Guardant Health Inc.
Invitae Corporation
GeneDx LLC
Travere Therapeutics
Centogene N.V.
Prevention Genetics
Medicover Hospitals
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
프레이저 증후군 시장 2029 : 새로운 기회를 제공하는 국가
프레이저 증후군 시장 2029 : 새로운 기회를 제공하는 부문
프레이저 증후군 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Fraser syndrome is a rare genetic disorder that affects the development of the kidneys and reproductive organs, and increases the risk of cancers such as gonadoblastoma. It is caused by mutations in the Wilms tumor 1 (WT1) gene, which is essential for normal kidney development. These genetic abnormalities disrupt organ formation and heighten the risk of cancer.
The main treatment approaches for Fraser syndrome include surgical intervention, hormone therapy, supportive care, and genetic counseling. Surgical intervention involves using medical instruments to treat, repair, or remove tissue or organs through incisions or other techniques. Diagnostic methods for Fraser syndrome include genetic testing, clinical evaluations, imaging studies, and biochemical tests. Symptoms commonly associated with the condition include hypospadias, nephropathy, hearing loss, and dental anomalies. Fraser syndrome affects various healthcare settings, such as hospitals, diagnostic centers, research institutions, and other medical providers.
The Fraser syndrome market research report is one of a series of new reports from The Business Research Company that provides Fraser syndrome market statistics, including the Fraser syndrome industry's global market size, regional shares, competitors with the Fraser syndrome market share, detailed Fraser syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the Fraser syndrome market. This Fraser syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The frasier syndrome market size has grown strongly in recent years. It will grow from $1.48 billion in 2024 to $1.59 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to several factors, including increasing awareness of rare genetic disorders, the rising prevalence of pediatric kidney diseases, a growing clinical focus on intersex conditions, more patient referrals to genetic counselors, and the increasing use of hormone therapy in congenital cases.
The frasier syndrome market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to factors such as the growing demand for personalized medicine, increasing early diagnosis through newborn screening programs, a rising focus on gender-affirming healthcare, greater accessibility to rare disease support services, and the growing prevalence of congenital nephrotic syndromes. Key trends in the forecast period include advancements in genetic testing technology, innovations in hormone replacement therapies, the development of precision nephrology tools, increased investment in rare disease research and development, and advancements in pediatric urology care solutions technology.
The rising prevalence of kidney-related diseases is expected to drive the growth of the Frasier syndrome market in the coming years. Kidney-related diseases, which include conditions that affect the structure or function of the kidneys, limit their ability to filter waste, balance fluids, and regulate essential physiological processes. The increasing incidence of kidney diseases is largely attributed to higher rates of diabetes and high blood sugar levels that damage kidney blood vessels, impairing their function. Frasier syndrome offers a deeper understanding of kidney-related diseases by focusing on the genetic mutations that affect kidney function. This insight into how genetic factors contribute to nephropathy aids in the diagnosis and management of kidney disorders. For example, in December 2024, the Australian Institute of Health and Welfare reported that chronic kidney disease (CKD) accounted for approximately 22,000 deaths in 2022, with a rising death rate from 56.7 per 100,000 in 2021 to 60.3 per 100,000 in 2022. As kidney-related diseases continue to increase, the Frasier syndrome market is expected to expand.
The growing investment in rare diseases is poised to accelerate the growth of the Frasier syndrome market. Rare diseases, affecting fewer than 1 in 2,000 people, are often chronic, progressive, and can be life-threatening or disabling. The increased investment in rare diseases is driven by the recognition of unmet medical needs and the opportunity for high returns through regulatory incentives, such as orphan drug designation, market exclusivity, and reduced development costs. Frasier syndrome underscores the need for targeted research and development, sparking investment in rare diseases by demonstrating the potential for effective, niche-specific therapies. For instance, in April 2024, Global Genes, a US-based nonprofit organization, reported that companies developing drugs for rare diseases raised $7.1 billion in the first quarter of 2024, a 307% increase from the $1.8 billion raised during the same period in 2023. This growing investment in rare diseases is further propelling the Frasier syndrome market.
The growing adoption of telemedicine is expected to drive the growth of the Frasier syndrome market as well. Telemedicine, which utilizes digital communication technologies to provide clinical healthcare services remotely, enables patients to consult with doctors, receive diagnoses, and manage treatments without physically visiting a healthcare facility. The convenience of telemedicine is driving its adoption, allowing patients to access healthcare services remotely, saving time, and reducing the need for travel, which enhances overall accessibility and efficiency. For patients with Frasier syndrome, telemedicine ensures access to specialized care, genetic counseling, and regular follow-up consultations. This improves the timeliness of diagnoses and the personalized management of the condition. In February 2023, a survey conducted by Rock Health, a US-based nonprofit organization, revealed that 80% of respondents had used telemedicine at least once, up from 72% in 2021. The growing adoption of telemedicine is thus contributing to the growth of the Frasier syndrome market.
Major players in the frasier syndrome market are Pfizer Inc, Bayer AG, Novo Nordisk, Merck KGaA, Quest Diagnostics Incorporated, Genentech Inc, Illumina Inc., Revvity Inc., Exact Sciences Corporation, Natera Inc., PTC Therapeutics, Myriad Genetics Inc., Fulgent Genetics Inc., Guardant Health Inc., Invitae Corporation, GeneDx LLC, Travere Therapeutics, Centogene N.V., Prevention Genetics, Medicover Hospitals.
North America was the largest region in the frasier syndrome market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in frasier syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the frasier syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The frasier syndrome market consists of revenues earned by entities by providing services such as genetic testing and counselling, hormone replacement therapy (HRT), kidney function monitoring and treatment, surgical interventions, and psychological and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The frasier syndrome market also includes sales of genetic testing kits, gene therapy products, surgical interventions, and renal dialysis equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Frasier Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on frasier syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for frasier syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The frasier syndrome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Frasier Syndrome Market Characteristics
3. Frasier Syndrome Market Trends And Strategies
4. Frasier Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Frasier Syndrome Growth Analysis And Strategic Analysis Framework
5.1. Global Frasier Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Frasier Syndrome Market Growth Rate Analysis
5.4. Global Frasier Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Frasier Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Frasier Syndrome Total Addressable Market (TAM)
6. Frasier Syndrome Market Segmentation
6.1. Global Frasier Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Intervention
Hormone Therapy
Supportive Care
Genetic Counseling
6.2. Global Frasier Syndrome Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing
Clinical Evaluation
Imaging Techniques
Biochemical Testing
6.3. Global Frasier Syndrome Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypospadias
Nephropathy
Hearing Loss
Dental Anomalies
6.4. Global Frasier Syndrome Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Research Institutes
Other End Users
6.5. Global Frasier Syndrome Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nephrectomy
Renal Transplantation
Testicular Biopsy
6.6. Global Frasier Syndrome Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Testosterone Replacement Therapy
Estrogen Therapy
Growth Hormone Therapy
6.7. Global Frasier Syndrome Market, Sub-Segmentation Of Supportive Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Pressure Management
Renal Replacement Therapy (Dialysis)
Pain Management
6.8. Global Frasier Syndrome Market, Sub-Segmentation Of Genetic Counseling, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preconception Counseling
Post-Diagnosis Counseling
Family Planning Guidance
7. Frasier Syndrome Market Regional And Country Analysis
7.1. Global Frasier Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Frasier Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
